KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Deferred Taxes: 2009-2025

Historic Deferred Taxes for Encompass Health (EHC) over the last 17 years, with Q3 2025 value amounting to -$2.1 million.

  • Encompass Health's Deferred Taxes changed 0.0% to -$2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.0 million, marking a year-over-year increase of 3953.49%. This contributed to the annual value of $10.7 million for FY2024, which is 17435.9% up from last year.
  • Encompass Health's Deferred Taxes amounted to -$2.1 million in Q3 2025, which was down 0.0% from -$3.5 million recorded in Q2 2025.
  • In the past 5 years, Encompass Health's Deferred Taxes registered a high of $35.6 million during Q4 2022, and its lowest value of -$8.8 million during Q2 2022.
  • For the 5-year period, Encompass Health's Deferred Taxes averaged around $3.3 million, with its median value being -$1.2 million (2022).
  • Its Deferred Taxes has fluctuated over the past 5 years, first surged by 52142.86% in 2021, then tumbled by 25200.0% in 2022.
  • Encompass Health's Deferred Taxes (Quarter) stood at $15.8 million in 2021, then skyrocketed by 125.32% to $35.6 million in 2022, then plummeted by 80.9% to $6.8 million in 2023, then grew by 26.47% to $8.6 million in 2024, then tumbled by 124.42% to -$2.1 million in 2025.
  • Its Deferred Taxes stands at -$2.1 million for Q3 2025, versus -$3.5 million for Q2 2025 and $8.8 million for Q1 2025.